ReviewWorld journal of gastroenterology2019
Improving cirrhosis care: The potential for telemedicine and mobile health technologies.
Review in World journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 45 citations in OpenAlex.
- Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis.World journal of hepatology · 2023Trial
- Assessing Acceptance and Intention to Use of Home Telemonitoring Among Patients with Liver Cirrhosis: Development and Initial Psychometric Validation of a TAM-Based Questionnaire.Diagnostics (Basel, Switzerland) · 2026Article
- Feasibility and acceptability of pharmacist-led remote patient monitoring for carvedilol dose titration in clinically significant portal hypertension.International journal of clinical pharmacy · 2026Article
- Usability Evaluation of the Karafs Application: A Qualitative Study Using the Think-Aloud Method.Health science reports · 2026Article
- A geospatial analysis of liver transplant centers and alcohol-related liver disease across the United States.Journal of liver transplantation · 2025Article
- Hepatology in the Digital Era: A Review of Telehealth Care for Liver Disease.Current gastroenterology reports · 2025Review
- Hub-and-Spoke regional system supported by telehealth for managing coeliac disease in Liguria: a mixed-methods survey followed by an observational pilot study.BMC health services research · 2025Observational
- Tele-medicine and its impact on academic medical centers: A narrative review.Journal of family medicine and primary care · 2024Review
- Prophylaxis of hepatic encephalopathy: current and future drug targets.Hepatology international · 2024Review
- Design, implementation, and impact of a cirrhosis-specific remote patient monitoring program.Hepatology communications · 2024Article
- Telemedicine in Patients Affected by Chronic Liver Disease: A Scoping Review of Clinical Outcomes and the Devices Evaluated.Journal of clinical medicine · 2023Article
- A novel smartphone scleral-image based tool for assessing jaundice in decompensated cirrhosis patients.Journal of gastroenterology and hepatology · 2023Article
- Review
- Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.Digestive diseases and sciences · 2022Review
- The Evolution and Future of Telehealth for Gastroenterology and Hepatology.Clinical liver disease · 2022Review
- The digital transformation of hepatology: The patient is logged in.Hepatology (Baltimore, Md.) · 2022Review
- Telemedicine based remote monitoring after liver transplantation: Feasible in a select group and a more stringent control of immunosuppression.Clinical transplantation · 2022Article
- Telemedicine Chronic Viral Hepatitis C Treatment during the Lockdown Period in Romania: A Pilot Study.International journal of environmental research and public health · 2021Article
- Strategies to Improve Delivery of Cirrhosis Care.Current treatment options in gastroenterology · 2021Review
- Impact of mobile health and medical applications on clinical practice in gastroenterology.World journal of gastroenterology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Decompensated cirrhosis is a condition associated with significant morbidity and mortality. While there have been significant efforts to develop quality metrics that ensure high-value care of these patients, wide variations in clinical practice exist. In this opinion review, we discuss the quality gap in the care of patients with cirrhosis, including low levels of compliance with recommended cancer screening and other clinical outcome and patient-reported outcome measures. We posit that innovations in telemedicine and mobile health (mHealth) should play a key role in closing the quality gaps in liver disease management. We highlight interventions that have been performed to date in liver disease and heart failure-from successful teleconsultation interventions in the care of veterans with cirrhosis to the use of telemonitoring to reduce hospital readmissions and decrease mortality rates in heart failure. Telemedicine and mHealth can effectively address unmet needs in the care of patients with cirrhosis by increasing preventative care, expanding outreach to rural communities, and increasing high-value care. We aim to highlight the benefits of investing in innovative solutions in telemedicine and mHealth to improve care for patients with cirrhosis and create downstream cost savings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.